Carlos Santos

Angstrom Bio, Inc. is a biotechnology company based in the United States that specializes in the study, diagnosis, and treatment of disease. The company is based in Austin, TX. The company's focus is on the development and deployment of AMpD, a technology that aims to deliver over 1,000,000 test results per day in 2021. The company applies machine learning and novel nucleotide chemistry to their work, with the goal of using machine intelligence for human health. The company was founded by David J. States, and the CEO is Carlos Santos.

Angstrom Bio, Inc. is a biotechnology company based in the United States that specializes in the study, diagnosis, and treatment of disease. The company is based in Austin, TX. The company's focus is on the development and deployment of AMpD, a technology that aims to deliver over 1,000,000 test results per day in 2021. The company applies machine learning and novel nucleotide chemistry to their work, with the goal of using machine intelligence for human health. The company was founded by David J. States, and the CEO is Carlos Santos.

Angstrom Bio, Inc. is a biotechnology company based in the United States that specializes in the study, diagnosis, and treatment of disease. The company is based in Austin, TX. The company's focus is on the development and deployment of AMpD, a technology that aims to deliver over 1,000,000 test results per day in 2021. The company applies machine learning and novel nucleotide chemistry to their work, with the goal of using machine intelligence for human health. The company was founded by David J. States, and the CEO is Carlos Santos.